BEHOLD phase 3 clinical development program of mocertatug rezetecan in ovarian and endometrial cancer. // Gynecologic Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S0090825826021803?dgcid=rss_sd_all
BEHOLD phase 3 clinical development program of mocertatug rezetecan in ovarian and endometrial cancer. Gynecologic Oncology. https://www.sciencedirect.com/science/article/pii/S0090825826021803?dgcid=rss_sd_all
“BEHOLD phase 3 clinical development program of mocertatug rezetecan in ovarian and endometrial cancer.” Gynecologic Oncology.
@article{article47152,
title = {BEHOLD phase 3 clinical development program of mocertatug rezetecan in ovarian and endometrial cancer},
journal = {Gynecologic Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S0090825826021803?dgcid=rss_sd_all}
}